The 20th century saw humanity develop in leaps and bounds, and without a doubt one of the most revolutionary advances was oral contraceptives, more commonly known as "the pill."
Jul 17, 2024
0
1
In a recent study, investigators at Beth Israel Deaconess Medical Center (BIDMC) led by Jan Heng, Ph.D., examined the effects of testosterone therapy in the breast tissue of 425 trans masculine individuals.
Jul 17, 2024
0
0
Current screening protocols fail to catch a notable number of people carrying genetic mutations associated with hereditary breast and ovarian cancer syndrome and Lynch syndrome, which increase the risk of developing certain ...
Jul 17, 2024
0
0
Hepatic, or liver, disease affects more than 100 million people in the U.S. About 4.5 million adults (1.8%) have been diagnosed with liver disease, but it is estimated that between 80 and 100 million adults in the U.S. have ...
Jul 17, 2024
0
0
University of Pittsburgh and UPMC Hillman Cancer Center researchers have developed a novel prompt, or 'nudge' embedded in the electronic health record that flags, for treating surgeons, older patients with early-stage breast ...
Jul 17, 2024
0
0
A new editorial paper titled "HER2-low and HER2-zero in breast cancer between prognosis, prediction and entity" has been published in Oncotarget.
Jul 16, 2024
0
0
Hormone modulating therapy (HMT) used for the treatment of breast cancer was associated with a 7% lower risk of developing Alzheimer's disease and related dementias later in life, according to a new study published in JAMA ...
Jul 16, 2024
0
19
A considerable proportion of women aged 39 to 49 years prefer to delay breast cancer screening, especially after a decision aid (DA) intervention, according to a study published online July 16 in the Annals of Internal Medicine.
Jul 16, 2024
0
0
A model co-designed by a professor at Anglia Ruskin University is expected to reduce the need for chemotherapy in up to 38% of breast cancer patients who would previously have been advised to consider the treatment.
Jul 12, 2024
0
6
Researchers from Queen Mary University London and Emory University used a novel AI-based analytic tool to better understand how tumor infiltrating lymphocytes (TILs) can predict which cases of Ductal Carcinoma in Situ (DCIS) ...
Jul 10, 2024
0
8
